Stock ENLV ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Enlivex Therapeutics Ltd.

Equities

ENLV

IL0011319527

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
1.67 USD +0.60% Intraday chart for Enlivex Therapeutics Ltd. +26.52% -38.15%
Apr. 22 Enlivex Therapeutics Says First Two Patients Dosed in Knee Osteoarthritis Trial MT
Apr. 16 Enlivex Therapeutics Receives Approval to Expand Trial of Allocetra to Treat Knee Osteoarthritis Into Denmark MT

Evolution of the average Target Price on Enlivex Therapeutics Ltd.

Price target over the last 5 years

History of analyst recommendation changes

3c59a0eb63b3d1f86a87e332c61bff.XQIkkXI285O_U2T1PLGc9Z9QEdoe7xzgbwTYDaSFngs.HjRcqS1mvt-IEAnMCP3IttwIc-pbmHeNWlyxaZTh5HI_ckHUHWaQqtpqKQ~9f41b7837640e80f9cda71696177243a

Analyst Recommendations on Enlivex Therapeutics Ltd.

HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating MT
HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating MT
HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.67 USD
Average target price
7 USD
Spread / Average Target
+319.16%
High Price Target
7 USD
Spread / Highest target
+319.16%
Low Price Target
7 USD
Spread / Lowest Target
+319.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Enlivex Therapeutics Ltd.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Consensus Enlivex Therapeutics Ltd.